- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
8
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
8 companies
AstraZeneca
Market Cap: UK£195.3b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£125.94
7D
-1.9%
1Y
22.3%
Gilead Sciences
Market Cap: US$169.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$134.28
7D
3.4%
1Y
24.1%
Chugai Pharmaceutical
Market Cap: JP¥12.1t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,325.00
7D
-0.9%
1Y
4.6%
WuXi AppTec
Market Cap: CN¥353.2b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥117.89
7D
-4.4%
1Y
42.7%
Orion Oyj
Market Cap: €10.9b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€77.40
7D
11.1%
1Y
11.4%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥51.6b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥114.70
7D
-6.7%
1Y
15.7%
Xiamen Amoytop Biotech
Market Cap: CN¥23.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥57.53
7D
3.3%
1Y
-23.8%
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩336,500.00
7D
5.3%
1Y
-40.7%